Lords Chloro Alkali Approves Q3 Results, Allots 35 Lakh Shares, Reappoints MD
Lords Chloro Alkali approved Q3 FY26 results and allotted 35 lakh equity shares worth ₹42.70 crore via warrant conversion. Mr. Ajay Virmani was reappointed as MD for 5 years from July 12, 2026. The EGM is on March 18, 2026.
The share allotment, while increasing the equity base, is a conversion of existing warrants. The re-appointment of the MD is a significant management event. The financial results are routine for the quarter.
The company reported financial results and approved the allotment of shares through warrant conversion, increasing its equity base. The re-appointment of the Managing Director for a long term also signals stability.
Lords Chloro Alkali Limited announced the outcome of its Board Meeting held on February 9, 2026. The board approved the un-audited financial results for the third quarter and nine months ended December 31, 2025, along with the Limited Review Report from the Statutory Auditors.
Furthermore, the company approved the allotment of 35,00,000 equity shares, aggregating to ₹42.70 crore, upon the conversion of 35,00,000 warrants. These warrants were issued at an issue price of ₹122 each, comprising a face value of ₹10 and a premium of ₹112. The allotment was made on a preferential basis to entities in the Promoter and Non-Promoter categories, including Mrs. Maneesha Dhir, Mr. Madhav Dhir, Ms. Srishti Dhir, Mrs. Snigdha Dhir, Mr. Ajay Virmani, M/s My Money Credits Private Limited, and M/s Mehak Infracon Private Limited.
Following this conversion, the company's paid-up equity share capital increased from 2,51,53,861 equity shares to 2,86,53,861 equity shares. The newly allotted shares will rank pari-passu with the existing equity shares.
In significant management decisions, the board approved the re-appointment of Mr. Ajay Virmani as the Managing Director for a further term of 5 years, effective July 12, 2026, subject to member approval at the ensuing EGM. The board also approved the payment of remuneration to Mr. Ajay Virmani and Mr. Madhav Dhir, along with an increase in the limit of managerial remuneration payable to directors, all subject to shareholder approval.
The company also received board approval to commence the process for an Employee Stock Option Plan (ESOP).
An Extra Ordinary General Meeting (EGM) of the Company is scheduled to be held on Wednesday, March 18, 2026. The board meeting commenced at 4:00 PM and concluded at 6:20 PM.
What to do with a filing like this
Lords Chloro Alkali Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lords Chloro Alkali Limited. Read the original for the full detail.